#USA #San Francisco #Cancer Immunotherapy #Parker Institute #Aimee Johnson

Parker Institute for Cancer Immunotherapy Welcomes New CMO

The Parker Institute for Cancer Immunotherapy (PICI) recently announced that Aimee Johnson will take on the role of Chief Marketing Officer. This strategic appointment comes as PICI gears up to expand its brand presence and influence within the cancer research community.

Aimee Johnson: A Wealth of Experience

Johnson brings an impressive résumé to PICI, boasting over 30 years of marketing expertise across diverse sectors such as technology, retail, consumer goods, and financial services. Throughout her career, she has achieved remarkable success in brand building, digital engagement, and converting complex innovations into accessible narratives for consumers and stakeholders alike.

With her extensive background, Johnson is uniquely positioned to lead PICI’s marketing initiatives, aiming to elevate awareness surrounding the institute's mission and its scientific advancements. Her focus will be on cultivating relationships with donors, partners, researchers, and other stakeholders, ultimately broadening the audience’s understanding of collaborative science’s crucial role in accelerating cancer treatment development.

A Vision for Growth

Dr. Karen R. Knudsen, CEO of PICI, expressed her enthusiasm about Johnson’s appointment, stating, “Aimee brings an exceptional track record of marketing iconic brands and connecting innovation to real-world impact.” She emphasized how crucial Johnson's abilities will be as PICI strives to enhance visibility and advance its mission to develop innovative cancer therapies.

Previously, Johnson served as Chief Marketing Officer at Zillow Group, where she effectively led the company’s marketing strategies for both business-to-business and business-to-consumer segments. Before that, she held key leadership positions at Starbucks for nearly 15 years, significantly impacting the development of initiatives such as Mobile Order & Pay and the Starbucks Rewards program.

Commitment to Change

In her new role at PICI, Johnson is excited to share the organization's vital work in the field of cancer immunotherapy. “At PICI, we bridge the gap between laboratory breakthroughs and patient treatments by funding groundbreaking research, uniting top cancer researchers, and facilitating clinical trials that expedite the delivery of therapies to patients,” she stated. Johnson’s vision is clear: to unite more donors, partners, and communities around PICI’s mission to make substantial strides in curing cancer.

About PICI

Founded in 2016 and motivated by Sean Parker's vision, the Parker Institute for Cancer Immunotherapy (PICI) is a nonprofit organization aimed at reshaping cancer treatment. By fostering collaboration among leading cancer centers, PICI drives high-risk, high-reward scientific progress, challenging the traditional models of cancer research. The organization not only focuses on innovative discoveries but also actively integrates entrepreneurship to expedite the journey from research to patient access. With over $4 billion raised and more than 1,000 investigators supported, PICI is determined to redefine the landscape of cancer treatment and enhance patient outcomes.

For those interested in learning more about PICI and its mission, please visit their official website at Parker Institute for Cancer Immunotherapy.